C4 Therapeutics Inc. (CCCC) - Analyst Comments

C4 Therapeutics Inc. (CCCC) – Analyst Comments

Feb 27, 2024 12:05 PM C4 Therapeutics (CCCC) PT Lowered to $18 at UBS, 'well funded, multiple catalysts - one to watch in '24'
Jan 29, 2024 04:27 AM JPMorgan Upgrades C4 Therapeutics (CCCC) to Neutral
May 30, 2023 06:26 AM
Feb 24, 2023 01:24 PM
Nov 4, 2022 06:11 AM
Apr 11, 2022 05:35 PM
Apr 11, 2022 07:00 AM
Apr 10, 2022 05:00 PM
Mar 10, 2022 04:23 AM
Feb 9, 2022 04:28 PM
Jan 3, 2022 07:47 AM
Sep 29, 2021 04:13 PM
Jun 24, 2021 07:59 AM
Jun 21, 2021 01:07 PM
Mar 31, 2021 01:40 AM
Mar 12, 2021 08:26 AM
Oct 27, 2020 07:53 AM
Oct 27, 2020 04:33 AM